Literature DB >> 4006304

Defective in vitro antibody production in response to pokeweed mitogen and influenza antigen in patients with Hodgkin's disease.

A Sigfusson, J W Babbage, R L Souhami.   

Abstract

Cultures of peripheral blood mononuclear cells (PBM) from 33 patients with Hodgkin's disease, were stimulated in vitro with pokeweed mitogen (PWM) or influenza antigen. Impaired production of immunoglobulin (Ig) of one or more of the three main classes (IgG, IgM and IgA) in PWM stimulated cultures was found in 22 patients and in 11 patients no Ig of any class was produced. Antibody to influenza virus was detected in PWM stimulated PBM cultures in 13 of 14 normal individuals, but in only four of 25 patients with treated Hodgkin's disease though IgG was produced in 16 of 25. Influenza antigen induced anti-influenza antibody production in 10 of 12 cultures from normal individuals but in only two of 22 from patients. The results confirm our earlier report of defective antibody production in vitro by PBM from patients with Hodgkin's disease and indicate that polyclonally activated production of immunoglobulins of several classes is defective, though in vivo humoral immunity is normal.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4006304      PMCID: PMC1577021     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  17 in total

1.  Anergy and skin homograft survival in Hodgkin's disease.

Authors:  W D KELLY; R A GOOD; R L VARCO
Journal:  Surg Gynecol Obstet       Date:  1958-11

2.  The immunoglobulins in Hodgkin's disease.

Authors:  D J Wagener; P J Van Munster; C Haanen
Journal:  Eur J Cancer       Date:  1976-09       Impact factor: 9.162

3.  Use of antibody-coated red cells for the sensitive detection of antigen and in rosette tests for cells bearing surface immunoglobulins.

Authors:  N R Ling; S Bishop
Journal:  J Immunol Methods       Date:  1977       Impact factor: 2.303

4.  Impaired in vitro lymphocyte transformation in Hodgkin's disease.

Authors:  E M Hersh; J J Oppenheim
Journal:  N Engl J Med       Date:  1965-11-04       Impact factor: 91.245

5.  Prostaglandin-producing suppressor cells in Hodgkin's disease.

Authors:  J S Goodwin; R P Messner; A D Bankhurst; G T Peake; J H Saiki; R C Williams
Journal:  N Engl J Med       Date:  1977-11-03       Impact factor: 91.245

6.  Impaired lymphocyte function in untreated Hodgkin's disease.

Authors:  R Levy; H S Kaplan
Journal:  N Engl J Med       Date:  1974-01-24       Impact factor: 91.245

7.  Quantitation of T and B lymphocytes and cellular immune function in Hodgkin's disease.

Authors:  A M Bobrove; Z Fuks; S Strober; H S Kaplan
Journal:  Cancer       Date:  1975-07       Impact factor: 6.860

8.  Monocyte-mediated inhibition of lymphocyte blastogenesis in Hodgkin disease.

Authors:  G P Schechter; F Soehnlen
Journal:  Blood       Date:  1978-08       Impact factor: 22.113

9.  Specific in vitro antibody response to influenza virus by human blood lymphocytes.

Authors:  R E Callard
Journal:  Nature       Date:  1979-12-13       Impact factor: 49.962

10.  Spectrum of immunodeficiencies with Hodgkin's disease.

Authors:  J J Twomey; A H Laughter; L Rice; R Ford
Journal:  J Clin Invest       Date:  1980-10       Impact factor: 14.808

View more
  2 in total

1.  Enhanced B cell survival in familial macroglobulinaemia is associated with increased expression of Bcl-2.

Authors:  H M Ogmundsdóttir; S Sveinsdóttir; A Sigfússon; I Skaftadóttir; J G Jónasson; B A Agnarsson
Journal:  Clin Exp Immunol       Date:  1999-08       Impact factor: 4.330

2.  Functional subsets of human helper-inducer cells defined by a new monoclonal antibody, UCHL1.

Authors:  S H Smith; M H Brown; D Rowe; R E Callard; P C Beverley
Journal:  Immunology       Date:  1986-05       Impact factor: 7.397

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.